Loading...

FITC anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_FITC_082808.jpg
BALB/cmouse bone marrow cells stained with 1A8 FITC (gated on myeloid cells)
  • 1A8_FITC_082808.jpg
    BALB/cmouse bone marrow cells stained with 1A8 FITC (gated on myeloid cells)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
127605 50 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127606 500 µg 210€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  3. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  4. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  5. Sanmarco LM, et al. 2022. Nature. 611:801. PubMed
  6. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  7. Le DT, et al. 2023. iScience. 26:106059. PubMed
  8. Veras FP, et al. 2023. Respir Res. 24:66. PubMed
  9. Doke T, et al. 2023. Nat Metab. 5:414. PubMed
  10. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  11. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  12. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  13. Park JA, et al. 2023. J Immunother Cancer. 11:. PubMed
  14. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  15. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  16. Silva BM, et al. 2023. J Clin Invest. 133:. PubMed
  17. Cui B, et al. 2023. Int Immunopharmacol. 120:110240. PubMed
  18. Oh J, et al. 2023. Nat Commun. 14:3278. PubMed
  19. Valladao A, et al. 2016. J Immunol. 197(12):4541-4551. PubMed
  20. Campbell IK, Leong D 2016. J Immunol. 197(11):4392-4402. PubMed
  21. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  22. Pohlmeier L, et al. 2021. Allergy. 76:2030. PubMed
  23. Li T, et al. 2022. J Exp Med. 219: . PubMed
  24. Yang Y, et al. 2022. FEBS J. 289:5279. PubMed
  25. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  26. Zhu Y, et al. 2023. J Ethnopharmacol. 301:115763. PubMed
  27. Xu Y, et al. 2023. EMBO Rep. 24:e55503. PubMed
  28. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  29. Pavliuchenko N, et al. 2023. Front Immunol. 13:1035226. PubMed
  30. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  31. Zong P, et al. 2022. Nat Cardiovasc Res. 1:344. PubMed
  32. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  33. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  34. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  35. Long M, et al. 2017. J Immunol. 198(2):862-872. PubMed
  36. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
  37. Mandraju R, et al. 2014. J Immunol. 192:4303. PubMed
  38. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  39. He R, et al. 2021. J Immunol. 206:2353. PubMed
  40. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  41. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  42. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  43. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  44. Patsalos A, et al. 2019. J Immunol. 203:1532. PubMed
  45. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  46. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  47. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  48. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  49. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  50. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  51. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  52. Huai W, et al. 2019. J Exp Med. 216:772. PubMed
  53. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  54. Torre S, et al. 2016. Nat Immunol. 10.1038/ni.3581. PubMed
  55. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  56. Wang C, et al. 2015. Sci Rep. 5: 14124. PubMed
  57. Han J, et al. 2022. FEBS J. 289:417. PubMed
  58. Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
  59. Castiglioni A, et al. 2015. PLoS One. 10:128094. PubMed
  60. Guesdon W, et al. 2015. J Infect Dis. 212: 1332 - 1340. PubMed
  61. Strother R, et al. 2016. J Immunol. 197(11):4301-4311. PubMed
  62. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  63. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  64. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  65. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  66. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  67. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  68. Ueki H, et al. 2020. Nat Protoc. 15:1041. PubMed
  69. Saika A, et al. 2020. FASEB Bioadv. 2:59. PubMed
  70. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  71. Wang H et al. 2017. Developmental cell. 40(6):566-582 . PubMed
  72. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  73. Billi AC, et al. 2019. JCI Insight. 4:8. PubMed
  74. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  75. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  76. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  77. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  78. Han YH, et al. 2021. Science. 373:. PubMed
  79. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  80. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
  81. Abad C, et al. 2014. J Leukoc Biol. 95:357. PubMed
  82. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  83. Liu Z, et al. 2016. J Biol Chem. 291: 1441 - 1447. PubMed
  84. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  85. Na YR, et al. 2020. Cell Rep. 107643:31. PubMed
  86. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  87. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  88. Wu X, et al. 2021. Elife. 10:. PubMed
  89. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
  90. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  91. Jin RM, et al. 2017. J Immunol. 198:352. PubMed
  92. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  93. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  94. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  95. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  96. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  97. Jacome-Galarza C, et al. 2011. J Bone Miner Res. 26:1207. PubMed
  98. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  99. Huixin Xu et al. 2018. EMBO molecular medicine. 10(9) pii: e8931. PubMed
  100. Minogue A, et al. 2014. Neurobiol Aging. 35:1442. PubMed
  101. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  102. Zheng J, et al. 2020. bioRxiv. . PubMed
  103. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  104. Geng S, et al. 2021. JCI Insight. 6:. PubMed
  105. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  106. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  107. Chen M, et al. 2021. Oncol Lett. 21:435. PubMed
  108. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  109. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  110. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  111. Roy K, et al. 2019. Immunity. 50:616. PubMed
  112. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  113. Christ A, et al. 2018. Cell. 172:162. PubMed
  114. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  115. Gousopoulos E, et al. 2016. Am J Pathol. 186:2193-2203. PubMed
  116. Radjabova V, et al. 2015. J Immunol. 195: 3149 - 3159. PubMed
  117. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  118. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  119. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  120. He J, et al. 2019. J Clin Invest. 130. PubMed
  121. Yu L, et al. 2019. Elife. 8:e46677. PubMed
  122. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  123. Wu M, et al. 2013. Proc Natl Acad Sci U S A. 110:9439. PubMed
  124. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  125. Ericson J, et al. 2014. PLoS One. 9:108553. PubMed
  126. Shih Y, et al. 2015. JPEN J Parenter Enteral Nutr. . PubMed
  127. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  128. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  129. Flögel U, et al. 2021. Nat Commun. 12:5847. PubMed
  130. Fischer KJ, et al. 2019. J Immunol. 202:2027. PubMed
  131. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  132. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  133. Uderhardt S, et al. 2019. Cell. 177:541. PubMed
  134. Hermetet F, et al. 2019. Nat Commun. 10:523. PubMed
  135. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  136. Shevchenko MA, et al. 2018. J Immunol Res. 8:53. PubMed
  137. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  138. Zheng J, et al. 2020. Nature. . PubMed
  139. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  140. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  141. Rebecca S Dickinson et al. 2017. Wellcome open research. 0.155555556 . PubMed
  142. Simpson K, et al. 2012. J Immunol. 189:5533. PubMed
  143. Giampazolias E, et al. 2021. Cell. . PubMed
  144. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  145. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  146. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  147. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  148. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  149. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  150. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  151. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  152. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  153. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  154. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  155. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  156. Qin W, et al. 2022. Bio Protoc. 12:e4287. PubMed
  157. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  158. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  159. Thomas DG et al. 2018. Cell reports. 25(13):3774-3785 . PubMed
  160. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  161. Chen ST et al. 2019. Cell host & microbe. 25(4):602-616 . PubMed
  162. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  163. Gorina R, et al. 2014. J Immunol. 192:324. PubMed
  164. Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed
  165. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  166. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  167. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  168. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  169. Makino A, et al. 2021. iScience. 24:103201. PubMed
  170. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  171. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  172. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  173. Wei Y, et al. 2021. Endocrinology. 162(8):. PubMed
  174. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  175. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  176. van Geffen C, et al. 2021. Front Immunol. 12:695933. PubMed
  177. Gu H, et al. 2021. Elife. 10:. PubMed
  178. Issah Y, et al. 2021. Elife. 10:. PubMed
  179. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  180. Danzer H, et al. 2020. Elife. 9:00. PubMed
  181. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  182. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  183. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  184. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  185. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  186. Chen J, et al. 2014. Cell Res. 24:1050. PubMed
  187. Xu Y, et al. 2014. Proc Natl Acad Sci U S A. 111:6371. PubMed
  188. Smith LK, et al. 2021. Elife. 10:. PubMed
  189. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  190. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  191. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  192. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  193. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  194. Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
  195. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  196. Stadtmann A, et al. 2015. J Immunol. 195: 1152-1161. PubMed
  197. Jia H, et al. 2016. J Immunol. 197: 859 - 871. PubMed
  198. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  199. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  200. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  201. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  202. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  203. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  204. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  205. Zhang H, et al. 2022. Commun Biol. 5:916. PubMed
  206. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
  207. Singh N, et al. 2016. Dis Model Mech. 9: 885 - 897. PubMed
  208. Cojohari O, Peppenelli M, Chan G 2016. Blood. 128: 529 - 541. PubMed
  209. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  210. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  211. Chuang LT, et al. 2021. Molecules. 26:. PubMed
RRID
AB_1236488 (BioLegend Cat. No. 127605)
AB_1236488 (BioLegend Cat. No. 127606)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
Ly-6G
Specificity Alt (DOES NOT SHOW ON TDS):
Ly-6G
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Spark Red™ 718 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Spark Blue™ 574 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Go To Top Version: 3    Revision Date: 01.06.2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account